Natural Killer Cells Therapeutics Market
Cell therapy, a new therapeutic approach that uses a patient’s own immune cells to attack tumor ... Read More
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.
This report contains market size and forecasts of Protein-based Multiplex Assays in Global, including the following market information:
Global Protein-based Multiplex Assays Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Protein-based Multiplex Assays market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Reagents & Consumables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Protein-based Multiplex Assays include Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Lab, QIAGEN, BD, Abcam, Seegene and Meso Scale Diagnostics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Protein-based Multiplex Assays companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Protein-based Multiplex Assays Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Protein-based Multiplex Assays Market Segment Percentages, by Type, 2021 (%)
Reagents & Consumables
Instruments & Accessories
Software & Services
Global Protein-based Multiplex Assays Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Protein-based Multiplex Assays Market Segment Percentages, by Application, 2021 (%)
Companion Diagnostics
Research & Development
Clinical Diagnostics
Global Protein-based Multiplex Assays Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Protein-based Multiplex Assays Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Protein-based Multiplex Assays revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Protein-based Multiplex Assays revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories
Cell therapy, a new therapeutic approach that uses a patient’s own immune cells to attack tumor ... Read More
Uncoated Intermittent catheters are the traditional intermittent catheters. It is in practice to ... Read More
Coated intermittent catheters were developed with the intent to reduce long term complications of ... Read More
Coated intermittent catheters were developed with the intent to reduce long term complications of ... Read More